(Q54414564)

29 May 2018

title

Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer. (English)

1 reference

29 May 2018

1 reference

1 reference

Dong Hoon Suh

1

0 references

author name string

Min A Kim

2

1 reference

29 May 2018

Haeryoung Kim

3

1 reference

29 May 2018

Mi-Kyung Kim

4

1 reference

29 May 2018

Hee Seung Kim

5

1 reference

29 May 2018

Hyun Hoon Chung

6

1 reference

29 May 2018

Yong-Beom Kim

7

1 reference

29 May 2018

Yong Sang Song

8

1 reference

29 May 2018

publication date

15 August 2013

1 reference

29 May 2018

Clinical and Experimental Medicine

published in

1 reference

29 May 2018

volume

14

1 reference

29 May 2018

issue

3

1 reference

29 May 2018

page(s)

345-353

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1007/s10238-013-0250-9

exact match

0 references

cites work

TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt.

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Targeted therapies in epithelial ovarian cancer: Molecular mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Major clinical research advances in gynecologic cancer in 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Metabolic approaches to overcoming chemoresistance in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Protein profiles in human ovarian cancer cell lines correspond to their metabolic activity and to metabolic profiles of respective tumor xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Hexokinase II detachment from the mitochondria potentiates cisplatin induced cytotoxicity through a caspase-2 dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Regulation of hexokinase binding to VDAC

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Whole-body positron emission tomography and positron emission tomography/computed tomography in gynecologic oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

FDG-PET/CT for diagnosis of primary ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Nucleocytoplasmic shuttling of hexokinase II in a cancer cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Effects of hypoxia on tumor metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Tissue Microarray: A rapidly evolving diagnostic and research tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Tissue microarrays: a current medical research tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Sugar-free approaches to cancer cell killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Therapeutic efficacy and safety of paclitaxel/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0250-9

Body mass index and survival in patients with epithelial ovarian cancer

21 January 2018

1 reference

12 December 2020

Expression of type 2 hexokinase and mitochondria-related genes in gastric carcinoma tissues and cell lines.

1 reference

12 December 2020

Reduced survival of patients with hepatocellular carcinoma expressing hexokinase II.

1 reference

12 December 2020

Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer

1 reference

12 December 2020

Respiratory competent mitochondria in human ovarian and peritoneal cancer

1 reference

12 December 2020

Prognostic value of GLUT-1 expression in ovarian surface epithelial tumors: a morphometric study

1 reference

12 December 2020

Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.

1 reference

12 December 2020

Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis.

1 reference

12 December 2020

Mammalian hexokinases and their abnormal expression in cancer

1 reference

12 December 2020

Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma

1 reference

12 December 2020

Relationship among glycolytic phenotype, grade, and histological subtype in ovarian carcinoma

1 reference

12 December 2020

10.1007/S10238-013-0250-9

Identifiers

DOI

1 reference

29 May 2018

PubMed ID

23949336

1 reference

29 May 2018